In 13,015 statin-treated patients from the Copenhagen General Population Study, serum apolipoprotein–B concentration was shown to be a more accurate marker of both all-cause mortality and myocardial infarction risk than non-HDL cholesterol or LDL-C (26). The gene discussed is APOB; the disease is myocardial infarction.